QuantumDX Inks Deal To Distribute IVD Tests In China

The CEO of QuantumDX, Jonathan O’Halloran, spoke to Medtech Insight about the benefits of selling diagnostics in China and argued for a pragmatic approach to IP protection when launching in a country where counterfeiting is common.

• Source: Shutterstock

UK-based QuantuMDx has signed a cooperation agreement with Sansure Biotech, a large in vitro diagnostics company based in Changsha, capital of China’s Hunan province.

The two companies will work together to expand the reach and testing breadth of QuantumDX’s Q-POC point-of-care platform. 

More from In Vitro Diagnostics

More from Diagnostics